FOLLOW US

America October 24, 2025 3 mins read

Eli Lilly to Acquire Adverum Biotechnologies

America ı By Rihem Akkouche

0 Comments

Eli Lilly to acquire Adverum Biotechnologies

Pharmaceutical powerhouse Eli Lilly and Co. announced Friday that it will acquire Adverum Biotechnologies, a clinical-stage gene therapy innovator targeting eye diseases, in a deal valued at up to $262 million. The move signals Lilly’s deepening commitment to genetic medicine and vision restoration therapies.

Advised by Ropes & Gray LLP, Lilly plans to launch a tender offer to purchase all outstanding shares of Adverum, represented by Cooley LLP, for $3.56 per share in cash, totaling approximately $74.7 million upfront. Investors could see an additional $8.91 per share through a contingent value right (CVR) if specific milestones are achieved — raising the total transaction value to about $261.6 million, or $12.47 per share.

A Strategic Bet on Vision and Gene Therapy

The acquisition strengthens Lilly’s foothold in genetic medicine, an area it has been aggressively expanding. Adverum’s pipeline is focused on innovative gene therapies designed to restore vision and prevent blindness, positioning the firm as a promising player in ophthalmic biotechnology.

At the heart of the deal lies Ixo-vec, Adverum’s lead gene therapy candidate targeting wet age-related macular degeneration (wAMD) — a chronic, progressive retinal disease that affects millions of elderly patients worldwide.

“Ixo-vec has the potential to transform wAMD treatment from chronic care with repeated injections to a one-time therapy,” said Andrew Adams, Lilly’s group vice president of Molecule Discovery. “We are eager to welcome Adverum’s team and accelerate this innovative medicine to patients.”

Financial Structure and Deal Mechanics

The transaction requires a majority tender of Adverum’s common stock and remains subject to customary closing conditions. Lilly expects the acquisition to close by the fourth quarter of 2025. If successful, Lilly will merge any untendered shares through a second-step merger at the same consideration.

Adverum’s board of directors unanimously approved the deal following what it described as a comprehensive evaluation process involving “numerous discussions with potential partners and buyers.”

“We are thrilled to join Lilly, a leader in chronic and age-related disease innovation,” said Dr. Laurent Fischer, Adverum’s president and CEO. “Their expertise and global reach will help accelerate our mission to advance genetic medicines for healthy aging.”

Financing and Clinical Continuity

Ahead of the deal’s completion, Adverum secured a promissory note agreement for a $65 million loan from Lilly, to be paid in four installments. The funds will support ongoing clinical and registrational activities for Ixo-vec, ensuring trial continuity while regulatory steps proceed.

A String of Bold Acquisitions

The Adverum deal is the latest in a series of strategic moves by Lilly to broaden its genetic medicine pipeline. In June 2025, the company struck a $1.3 billion agreement to acquire Verve Therapeutics, and previously absorbed Akouos Inc. in 2022 to enhance its gene therapy platform.

With this acquisition, Lilly reinforces its trajectory toward pioneering advanced therapies that merge genetics, vision science, and precision medicine — reshaping the pharmaceutical landscape for decades to come.

Legal Advisors

  • For Eli Lilly: Ropes & Gray LLP — Partners Emily Oldshue, Dan Coyne, Renata Ferrari, Pamela Glazier, Geoffrey Lin, Cristi Schwarzman, David Kaye, David Peloquin, and Greg Levine.

  • For Adverum: Cooley LLP — Partners Bill Roegge and Jason Kent.

Previous Article

Crusoe Rockets Toward $10B Valuation After Massive $1.375B Funding Round

Read More
4594 Posts

Rihem Akkouche

Rihem Akkouche is a passionate journalist dedicated to shedding light on compelling stories, sparking conversations, and fostering a more informed world.

Discussion

No comments yet. Be the first to join the discussion!

Don’t Miss It
America November 15, 2026 The Orange County School Board approves health insurance plan By – Tyler Brooks
America November 15, 2026 Nonprofits sue five tech giants to freeze the AI arms race By – Tyler Brooks
America November 15, 2026 FAA Says No CyberAttack Indicated: Ground Stop Halted Saturday By – Jackie Allen
America November 15, 2026
‘Somebody Hit Us’: UPS Cargo Jet…

MIAMI, Fla. — A UPS cargo jet and a Copa…

By – Derek Johnson
America November 15, 2026
Supreme Court Agrees to Decide Whether…

WASHINGTON, D.C. — The Supreme Court has agreed to decide…

By – Derek Johnson
America November 15, 2026
America Loses Its Measles-Free Status for…

WASHINGTON, D.C. — For the first time in a quarter…

By – Derek Johnson
America November 15, 2026
Sean Duffy’s FAA Ground Stop Story…

By Samuel LĂłpez | USA Herald WASHINGTON – The Federal…

By – Samuel Lopez
America November 14, 2026
Worldwide Cyberattack Report — November 14,…

WASHINGTON – Cyberattacks are unfolding across the United States, Europe,…

By – Samuel Lopez
America November 14, 2026
Rosa Leyva Murder: Oregon Man Killed…

OREGON CITY, Ore. — Rosa Leyva, 61, was fatally shot…

By – Jackie Allen
America November 14, 2026
Golden State Valkyries Star Gabby Williams…

 Golden State Valkyries forward Gabby Williams believes Indiana Fever star…

By – Jackie Allen
America November 14, 2026
Jensen Huang Lawyers Up With Trump-Linked…

SAN FRANCISCO, Calif. – Former NVIDIA CEO Jensen Huang has…

By – Samuel Lopez
America November 14, 2026
Starship Blasts Off as FAA Outage…

WASHINGTON — SpaceX launched Starship from Texas on Friday while…

By – Michallie K Harrison
America November 14, 2026
Flights Grounded, Email Down: Two Days…

WASHINGTON — Two days of tech outages disrupted air travel…

By – Michallie K Harrison
America November 14, 2026
Three Nuclear Superpowers, One Table: White…

WASHINGTON, D.C. — President Donald Trump will sit down with…

By – Derek Johnson
America November 14, 2026
“A Miracle on the Mississippi”: Tanker…

NEW ORLEANS, La. — Passengers on a docked Mississippi River…

By – Derek Johnson
America November 13, 2026
Blue Wave, New Fight: Van Hollen…

WASHINGTON — Sen. Chris Van Hollen is challenging Chuck Schumer…

By – Michallie K Harrison
America November 13, 2026
Logan Circle Shooting: Police Say Gunman…

WASHINGTON — The gunman in Thursday’s Logan Circle shooting waited…

By – Michallie K Harrison
America November 13, 2026
The Blue Wave Gets Bluer: Scott…

The Democratic blue wave grew Wednesday as Scott Colom defeated…

By – Michallie K Harrison
America November 12, 2026
FINRA Bars Minnesota Broker Who Forged…

The insurance wife signature forging suit ended the way regulators…

By – Tyler Brooks
America November 12, 2026
SoftBank Loses $7 Billion as AI…

Key Takeaways SoftBank Group reported a $7 billion quarterly net…

By – Jackie Allen
America November 12, 2026
Zurich Insurance reports 7% rise in…

The Zurich 7% rise in P&C premiums landed Thursday, and…

By – Tyler Brooks
America November 13, 2026
Who Was Guarding the Chips? Commerce…

WASHINGTON, D.C. — The Nvidia scandal that toppled one of…

By – Derek Johnson
America November 12, 2026
Pinion US to Acquire Catlin Specialty:…

The plan for Pinion US to acquire Catlin Specialty just…

By – Tyler Brooks
America November 12, 2026
Elon Musk Says Hiring Jensen Huang…

Elon Musk has expressed interest in hiring Jensen Huang, the…

By – Jackie Allen
America November 12, 2026
Microsoft Outlook Goes Down Nationwide

The Microsoft Outlook down reports started piling up on Thursday,…

By – Rachel Moore
America November 12, 2026
Mark McGuinn Death: Country Singer Behind…

The Mark McGuinn death closes the book on a career…

By – Rachel Moore
America November 12, 2026
1 killed, 4 hurt in Logan…

The DC shooting began just before 8 a.m. Thursday, when…

By – Rachel Moore
America November 11, 2026
Brooklyn Building Collapse Kills 2 as…

A Brooklyn building collapse killed at least two people and…

By – Michallie K Harrison
America November 11, 2026
A Veterans Day Betrayal: House Advances…

OPINION | The Republican-led House marked Veterans Day by advancing…

By – Michallie K Harrison
America November 10, 2026
Vitamin K Deficiency Bleeding: Why the…

A single injection administered in the first hours of life…

By – Tyler Brooks
America November 10, 2026
Infant Bleeding Surges as Vitamin K…

Infant bleeding rose as fewer newborns received vitamin K shots,…

By – Michallie K Harrison
America November 7, 2026
Can Elephants Sue For Freedom? Hawaii…

What’s at Stake for Mari and Vaigai A legal first…

By – Samuel Lopez
America November 7, 2026
On Monday Supreme Court Weighs Whether…

What’s at Stake for Federal Prisoners A prisoner’s broken tailbone…

By – Samuel Lopez
America November 8, 2026
Dana White Reportedly Declines Trump White…

By Samuel Lopez – USA Herald | November 8, 2026…

By – Samuel Lopez
America November 7, 2026
Mike Tyson And Ric Flair Score…

Inside the $50 Million Legal Battle A federal judge rejected…

By – Samuel Lopez
America November 5, 2026
Dallas Cowboys Face  Crisis After Crushing…

By Jackie Allen | USA Herald The Dallas Cowboys are…

By – Jackie Allen
America November 4, 2026
WNBA: DeWanna Bonner Makes Emotional Admission…

ATLANTA — The WNBA Finals ended in heartbreak for the…

By – Jackie Allen
America November 4, 2026
InĂ©s GĂłmez Mont Arrested by ICE…

MIAMI —  InĂ©s GĂłmez Mont, a former television personality who…

By – Jackie Allen
America October 31, 2026
Bill Belichick and Jordon Hudson Reportedly End…

Bill Belichick and Jordon Hudson reportedly ended their romantic relationship…

By – Jackie Allen

No posts found.

No posts found.

Signup for the USA Herald
exclusive Newsletter